Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The Science of the Total Environment|September 30, 2021
Model-based ensembles: Lessons learned from retrospective analysis of COVID-19 infection forecasts across 10 countriesMartin Drews, Pavan Kumar, Ram Kumar Singh, et al.
IEEE Access : Practical Innovations, Open Solutions|November 23, 2021
Short-Term Statistical Forecasts of COVID-19 Infections in IndiaRam Kumar Singh, Martin Drews, Manuel De La Sen, et al.
JMIR Public Health and Surveillance|May 12, 2020
Prediction of the COVID-19 Pandemic for the Top 15 Affected Countries: Advanced Autoregressive Integrated Moving Average (ARIMA) ModelRam Kumar Singh, Meenu Rani, Akshaya Srikanth Bhagavathula, et al.
Scientific Reports|April 17, 2021
Highlighting the compound risk of COVID-19 and environmental pollutants using geospatial technologyRam Kumar Singh, Martin Drews, Manuel De la Sen, et al.
Research Square|January 23, 2024
Novel Anti-B-cell Maturation Antigen Alpha-Amanitin Antibody-drug Conjugate HDP-101 Shows Superior Activity to Belantamab Mafodotin and Enhanced Efficacy in Deletion 17p Myeloma ModelsRam Kumar Singh, Richard J Jones, Fazal Shirazi, et al.
Environment, Development and Sustainability|February 14, 2023
Nitrogen dioxide as proxy indicator of air pollution from fossil fuel burning in New Delhi during lockdown phases of COVID-19 pandemic period: impact on weather as revealed by Sentinel-5 precursor (5p) spectrometer sensorPavan Kumar, Aishwarya, Prashant Kumar Srivastava, et al.
Blood Advances|September 14, 2020
Targeting phosphatidylinositol 3 kinase-β and -δ for Bruton tyrosine kinase resistance in diffuse large B-cell lymphomaNeeraj Jain, Satishkumar Singh, Georgios Laliotis, et al.
Blood|February 10, 2019
Ubiquitin-activating enzyme inhibition induces an unfolded protein response and overcomes drug resistance in myelomaJunling Zhuang, Fazal Shirazi, Ram Kumar Singh, et al.
Leukemia|March 28, 2018
Protein targeting chimeric molecules specific for bromodomain and extra-terminal motif family proteins are active against pre-clinical models of multiple myelomaXiaohui Zhang, Hans C Lee, Fazal Shirazi, et al.
Blood Neoplasia|February 2, 2026
Mezigdomide combined with bortezomib disrupts the cell cycle and elicits superior antitumor effects in multiple myelomaChad C Bjorklund, Marta Larrayoz, Jian Kang, et al.
Pageof 2